An in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain

Typeset version

 

TY  - CONF
  - Donovan, MD and O'Brien, FE and Boylan, GB and Griffin, BT and Cryan, JF
  - 27th ECNP Congress
  - An in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain
  - 2014
  - Unknown
  - Validated
  - 0
  - ()
  - Berlin
  - P. 7. c. 002
DA  - 2014/NaN
ER  - 
@inproceedings{V281057373,
   = {Donovan, MD and O'Brien, FE and Boylan, GB and Griffin, BT and Cryan, JF},
   = {27th ECNP Congress},
   = {{An in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain}},
   = {2014},
   = {Unknown},
   = {Validated},
   = {0},
   = {()},
   = {Berlin},
   = {{P. 7. c. 002}},
  source = {IRIS}
}
AUTHORSDonovan, MD and O'Brien, FE and Boylan, GB and Griffin, BT and Cryan, JF
TITLE27th ECNP Congress
PUBLICATION_NAMEAn in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain
YEAR2014
MONTHUnknown
STATUSValidated
PEER_REVIEW0
TIMES_CITED()
SEARCH_KEYWORD
EDITORS
START_PAGE
END_PAGE
LOCATIONBerlin
START_DATE
END_DATE
ABSTRACTP. 7. c. 002
FUNDED_BY
URL
DOI_LINK
FUNDING_BODY
GRANT_DETAILS